Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
International Pharmacopsychiatry
|
January 1, 1979
[Examination of the retest reliability of the findings of the first psychopathological examination (AMP system)]
B Woggon, B Jau, H Meyer, et al.
International Pharmacopsychiatry
|
January 1, 1977
Antipsychotic effects, side effects and effective dosis of the butyrophenone lenperone (AHR 2277)
B Woggon, A Franke, H Hucker, et al.
International Pharmacopsychiatry
|
January 1, 1977
[Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial]
B Woggon, P Dick, H J Fleischhauer, et al.
Arzneimittel-Forschung
|
January 1, 1984
Results of a multicenter AMDP study with fluperlapine in schizophrenic patients
B Woggon, K Heinrich, B Küfferle, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten
|
September 17, 1976
[Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)]
B Woggon, J Angst, M Gmuer, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten
|
December 31, 1975
Comparison of a new antidepressive, lofepramine, with imipramine in a double-blind multicentre trial
B Woggon, J Angst, M Bleuler, et al.
Therapeutic Drug Monitoring
|
February 1, 1992
Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline
P Baumann, J W Meyer, M Amey, et al.
Neuropsychobiology
|
January 1, 1984
Antipsychotic efficacy of fluperlapine. An open multicenter trial
B Woggon, J Angst, M Bartels, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
International Pharmacopsychiatry
|
January 1, 1979
[Examination of the retest reliability of the findings of the first psychopathological examination (AMP system)]
B Woggon, B Jau, H Meyer, et al.
International Pharmacopsychiatry
|
January 1, 1977
Antipsychotic effects, side effects and effective dosis of the butyrophenone lenperone (AHR 2277)
B Woggon, A Franke, H Hucker, et al.
International Pharmacopsychiatry
|
January 1, 1977
[Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial]
B Woggon, P Dick, H J Fleischhauer, et al.
Arzneimittel-Forschung
|
January 1, 1984
Results of a multicenter AMDP study with fluperlapine in schizophrenic patients
B Woggon, K Heinrich, B Küfferle, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten
|
September 17, 1976
[Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)]
B Woggon, J Angst, M Gmuer, et al.
Archiv Fur Psychiatrie Und Nervenkrankheiten
|
December 31, 1975
Comparison of a new antidepressive, lofepramine, with imipramine in a double-blind multicentre trial
B Woggon, J Angst, M Bleuler, et al.
Therapeutic Drug Monitoring
|
February 1, 1992
Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline
P Baumann, J W Meyer, M Amey, et al.
Neuropsychobiology
|
January 1, 1984
Antipsychotic efficacy of fluperlapine. An open multicenter trial
B Woggon, J Angst, M Bartels, et al.
Page
of 6